References:
- Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, et al.
Termination of malignant ventricular arrhythmias with an implanted
automatic defibrillator in human beings. N Engl J Med.
1980;303(6):322-4.
- Cannom DS, Prystowsky EN. The evolution of the implantable
cardioverter defibrillator. Pacing Clin Electrophysiol.
2004;27(3):419-31.
- Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis
AB, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With
Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A
Report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the Heart
Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91-e220.
- Kuschyk J, Muller-Leisse J, Duncker D, Tulumen E, Fastenrath F,
Fastner C, et al. Comparison of transvenous vs subcutaneous
defibrillator therapy in patients with cardiac arrhythmia syndromes
and genetic cardiomyopathies. Int J Cardiol. 2021;323:100-5.
- Lambiase PD, Theuns DA, Murgatroyd F, Barr C, Eckardt L, Neuzil P, et
al. Subcutaneous implantable cardioverter-defibrillators: long-term
results of the EFFORTLESS study. Eur Heart J. 2022;43(21):2037-50.
- Boveda S, Lenarczyk R, Fumagalli S, Tilz R, Goscinska-Bis K, Kempa M,
et al. Factors influencing the use of subcutaneous or transvenous
implantable cardioverter-defibrillators: results of the European Heart
Rhythm Association prospective survey. Europace. 2018;20(5):887-92.
- Lin, G., Nishimura, R. A., Connolly, H. M., Dearani, J. A., Sundt, T.
M., & Hayes, D. L. (2005). Severe symptomatic tricuspid valve
regurgitation due to permanent pacemaker or implantable
cardioverter-defibrillator leads. Journal of the American
College of Cardiology , 45 (10), 1672-1675.
- Zhang, X. X., Wei, M., Xiang, R., Lu, Y. M., Zhang, L., Li, Y. D., …
& Zhou, X. H. (2022). Incidence, risk factors, and prognosis of
tricuspid regurgitation after cardiac implantable electronic device
implantation: a systematic review and meta-analysis. Journal of
Cardiothoracic and Vascular Anesthesia , 36 (6), 1741-1755.
- Breeman, K. T. N., Peijster, A. J. L., De Bruin-Bon, H. A. C. M.,
Pepplinkhuizen, S., Van der Stuijt, W., De Veld, J. A., … & Knops,
R. E. (2023). Worsening tricuspid regurgitation after ICD implantation
is rather due to transvenous lead than natural
progression. International journal of cardiology , 376 ,
76-80.
- Anvardeen, K., Rao, R., Hazra, S., Hay, K., Dai, H., Stoyanov, N., …
& Chan, K. L. (2019). Prevalence and significance of tricuspid
regurgitation post-endocardial lead placement. JACC:
Cardiovascular Imaging , 12 (3), 562-564.
- Mondésert B, Bashir J, Philippon F, Dubuc M, Amit G, Exner D, Joza J,
Birnie DH, Lane C, Tsang B, Korley V, Spears D, Ling A, Djuric A,
Crystal E, Hruczkowski T, Roux JF, Carroll S, Essebag V, Krahn AD,
Healey JS. Rationale and design of the randomized prospective ATLAS
study: Avoid Transvenous Leads in Appropriate Subjects. Am Heart J.
2019 Jan;207:1-9. doi: 10.1016/j.ahj.2018.09.008. Epub 2018 Oct 9.
PMID: 30399474.
- Nordkamp, L. R. O., Brouwer, T. F., Barr, C., Theuns, D. A., Boersma,
L. V., Johansen, J. B., … & Knops, R. E. (2015). Inappropriate
shocks in the subcutaneous ICD: incidence, predictors and
management. International journal of cardiology , 195 ,
126-133.
- Willy K, Reinke F, Rath B, Ellermann C, Wolfes J, Bogeholz N, et al.
Pitfalls of the S-ICD therapy: experiences from a large tertiary
centre. Clin Res Cardiol. 2021;110(6):861-7.
- Pothineni NVK, Cherian T, Patel N, Smietana J, Frankel DS, Deo R, et
al. Subcutaneous Implantable Cardioverter-defibrillator Explantation-A
Single Tertiary Center Experience. J Innov Card Rhythm Manag.
2022;13(4):4947-53.
- Sink, J., Peigh, G., Speakman, B., Banno, J., Sanders, D., Nso, N.,
… & Verma, N. (2024). Correlation between high-and low-voltage
impedance measurements following subcutaneous implantable
cardioverter-defibrillator implantation. Heart
rhythm , 21 (4), 492-494.
- Frankel DS, Burke MC, Callans DJ, Stivland TM, Duffy E, Epstein AE.
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous
Implantable Cardioverter-Defibrillator. JACC Clin Electrophysiol. 2018
May;4(5):652-659. doi: 10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2.
PMID: 29798794.
- Amin, Anish K., et al. ”Factors associated with high-voltage impedance
and subcutaneous implantable defibrillator ventricular fibrillation
conversion success.” Circulation: Arrhythmia and
Electrophysiology 12.4 (2019): e006665.
- Burke MC, Gold MR, Knight BP, Barr CS, Theuns D, Boersma LVA, et al.
Safety and Efficacy of the Totally Subcutaneous Implantable
Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study
and EFFORTLESS Registry. J Am Coll Cardiol. 2015;65(16):1605-15.
- Knops RE, Pepplinkhuizen S, Delnoy P, Boersma LVA, Kuschyk J, El-Chami
MF, et al. Device-related complications in subcutaneous versus
transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur
Heart J. 2022;43(47):4872-83.
- Gold, M. R., Aasbo, J. D., Weiss, R., Burke, M. C., Gleva, M. J.,
Knight, B. P., Miller, M. A., Schuger, C. D., Carter, N., Leigh, J.,
Brisben, A. J., & El-Chami, M. F. (2022). Infection in patients with
subcutaneous implantable cardioverter-defibrillator: Results of the
S-ICD Post Approval Study. Heart rhythm , 19 (12),
1993-2001. https://doi.org/10.1016/j.hrthm.2022.07.031
- Harcombe, A. A., Newell, S. A., Ludman, P. F., Wistow, T. E.,
Sharples, L. D., Schofield, P. M., … & Petch, M. C. (1998). Late
complications following permanent pacemaker implantation or elective
unit replacement. Heart , 80 (3), 240-244.
- Klug, D., Balde, M., Pavin, D., Hidden-Lucet, F., Clementy, J.,
Sadoul, N., … & Kacet, S. (2007). Risk factors related to
infections of implanted pacemakers and cardioverter-defibrillators:
results of a large prospective
study. Circulation , 116 (12), 1349-1355.
- Catanchin, A., Murdock, C. J., & Athan, E. (2007). Pacemaker
infections: a 10-year experience. Heart, Lung and
Circulation , 16 (6), 434-439.
- Sohail, M. R. (2007). Management of infected pacemakers and
implantable cardioverter-defibrillators. Internal Medicine
Journal , 37 (7), 509-10.
- Gasperetti, A., Schiavone, M., Ziacchi, M. et al. Combined Use
of S-ICD and Absorbable Antibacterial Envelopes: A Proof-of-concept
Study. J Interv Card Electrophysiol (2022).
https://doi.org/10.1007/s10840-022-01222-z
- Hoster C, Rahman A, Goyal A, Peigh G, Trohman R, Knight BP, Huang H,
Krishnan K, Larsen T, Mazur A, Sharma P, Engelstein E, Verma N,
Wasserlauf J. Subcutaneous implantable cardioverter-defibrillator
implantation position predicts successful defibrillation in obese and
non-obese patients. J Interv Card Electrophysiol. 2023 Jan 3. doi:
10.1007/s10840-022-01462-z. Epub ahead of print. PMID: 36596954.
- Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NA, 3rd,
et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for
Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the
American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. Heart Rhythm. 2012;9(10):1737-53.